27387-90-2Relevant articles and documents
Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5- dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl] -3-thiophenecarboxylic Acid (BMS-587101) - A small molecule antagonist of leukocyte function associated antigen-1
Potin, Dominiques,Launay, Michele,Monatlik, Francoise,Malabre, Patrice,Fabreguettes, Maud,Fouquet, Andre,Maillet, Magali,Nicolai, Eric,Dorgeret, Lo?c,Chevallier, Fran?ois,Besse, Dominique,Dufort, Monique,Caussade, Fran?ois,Ahmad, Syed Z.,Stetsko, Dawn K.,Skala, Stacey,Davis, Patricia M.,Balimane, Praveen,Patel, Karishma,Yang, Zheng,Marathe, Punit,Postelneck, Jennifer,Townsend, Robert M.,Goldfarb, Valentina,Sheriff, Steven,Einspahr, Howard,Kish, Kevin,Malley, Mary F.,DiMarco, John D.,Gougoutas, Jack Z.,Kadiyala, Pathanjali,Cheney, Daniel L.,Tejwani, Ravindra W.,Murphy, Denette K.,Mcintyre, Kim W.,Yang, Xiaoxia,Chao, Sam,Leith, Leslie,Xiao, Zili,Mathur, Arvind,Chen, Bang-Chi,Wu, Daugh-Rurng,Traeger, Sarah C.,McKinnon, Murray,Barrish, Joel C.,Robl, Jeffrey A.,Iwanowicz, Edwin J.,Suchard, Suzanne J.,Dhar, T. G. Murali
, p. 6946 - 6949 (2006)
LFA-1 (leukocyte function-associated antigen-1), is a member of the β2-integrin family and is expressed on all leukocytes. This letter describes the discovery and preliminary SAR of spirocyclic hydantoin based LFA-1 antagonists that culminated in the iden
Kilogram synthesis of a LFA-1/ICAM inhibitor
Delmonte, Albert J.,Waltermire, Robert E.,Fan, Yu,McLeod, Douglas D.,Gao, Zhinong,Gesenberg, Kirsten D.,Girard, Kevin P.,Rosingana, Miguel,Wang, Xuebao,Kuehne-Willmore, Jennifer,Braem, Alan D.,Castoro, John A.
scheme or table, p. 553 - 561 (2011/07/30)
The process development and the kilogram-scale synthesis of BMS-587101 (1) are described. The synthesis features a [3 + 2] azomethine ylide cycloaddition to efficiently build the spirocyclic core in a diastereoselective fashion followed by a classical res
Crystalline forms and process for preparing spiro-hydantoin compounds
-
Page/Page column 24, (2010/10/20)
A process is provided for preparing spiro-hydantoin compounds of the formula II wherein Z is N or CR4b; K and L are independently O or S; Ar is an optionally substituted aryl or heteroaryl; A2 is a linker, G′ is a linker; Q is a link